Vinorelbine and respiratory failure Patient Reports February 12, 2012

Vinorelbine Side Effects Report #5468887-1
Vinorelbine side effect was reported by a Consumer or non-health professional from UNITED STATES on Sept 17, 2007. Female patient, 72 years of age, was diagnosed with non-small cell lung cancer and was treated with Vinorelbine. After drug was administered, patient experienced the following side effects: respiratory failure. Vinorelbine dosage: unknown. During the same period patient was treated with DOCETAXEL. Patient died.

Vinorelbine Side Effects Report #5468916-5
Vinorelbine side effect was reported by a Consumer or non-health professional from UNITED STATES on Sept 17, 2007. Female patient, 72 years of age, was diagnosed with non-small cell lung cancer and was treated with Vinorelbine. After drug was administered, patient experienced the following side effects: conduction disorder, dyspnoea, renal failure, respiratory failure. Vinorelbine dosage: unknown. During the same period patient was treated with DOCETAXEL. Patient died.

Vinorelbine Side Effects Report #4763683-2
Vinorelbine side effect was reported by a Physician from GERMANY on Aug 29, 2005. Male patient, 64 years of age, was diagnosed with non-small cell lung cancer and was treated with Vinorelbine. After drug was administered, patient experienced the following side effects: haemodialysis, multi-organ failure, radiation oesophagitis, radiation pneumonitis, renal impairment, respiratory failure, stenotrophomonas infection, thrombophlebitis. Vinorelbine dosage: unknown. During the same period patient was treated with CISPLATIN, PACLITAXEL. Patient was hospitalized. Patient died on 07/30/2005.

Vinorelbine Side Effects Report #5105997-2
Vinorelbine side effect was reported by a Physician from UNITED STATES on Aug 30, 2006. Female patient was diagnosed with non-small cell lung cancer and was treated with Vinorelbine. After drug was administered, patient experienced the following side effects: respiratory failure. Vinorelbine dosage: 25 MG/M**2;IV. During the same period patient was treated with DOCETAXEL. Patient died.